How have AMPE shares performed in 2024?

Ampio Pharmaceuticals' stock was trading at $2.05 at the beginning of 2024. Since then, AMPE stock has decreased by 87.8% and is now trading at $0.25. View the best growth stocks for 2024 here .

When is Ampio Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our AMPE earnings forecast .

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) released its quarterly earnings data on Wednesday, March, 27th. The company reported ($2.48) earnings per share for the quarter.

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals shares reverse split on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA) , Agenus (AGEN) and American Airlines Group (AAL) .

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free AMPE Stock Alerts

$0.25

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.22
▼
$0.27
50-Day Range: $0.25
▼
$2.30
52-Week Range: $0.14
▼
$8.30

Volume: 46,877 shs
Average Volume: 153,591 shs
Market Capitalization: $285,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Ampio Pharmaceuticals alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

AMPE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AMPE Stock News Headlines

April 13, 2024 | americanbankingnews.com

Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

April 3, 2024 | finance.yahoo.com

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 3, 2024 | prnewswire.com

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

March 27, 2024 | investorplace.com

AMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023

March 26, 2024 | money.usnews.com

Ampio Pharmaceuticals Inc

March 26, 2024 | finanznachrichten.de

Ampio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistration

March 26, 2024 | msn.com

US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 25, 2024 | finance.yahoo.com

Ampio Announces Voluntary Delisting and SEC Deregistration

February 29, 2024 | msn.com

Ampio Pharmaceuticals, Ironwood, Incannex among healthcare movers

February 15, 2024 | finanznachrichten.de

Ampio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling Studies

February 14, 2024 | prnewswire.com

Ampio Provides Update on Results from Pre-IND Enabling Studies

January 26, 2024 | msn.com

Ampio Pharmaceuticals Announces At-The-Market Stock Offering

December 28, 2023 | seekingalpha.com

Sociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' pack

December 1, 2023 | msn.com

What's Going On With Ampio Pharmaceuticals Stock?

December 1, 2023 | msn.com

Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers

November 30, 2023 | benzinga.com

Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group

October 5, 2023 | finance.yahoo.com

Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

October 4, 2023 | finance.yahoo.com

Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now

September 26, 2023 | finance.yahoo.com

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

September 7, 2023 | thestreet.com

Ampio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary Endpoint

August 31, 2023 | seekingalpha.com

Ampio Pharmaceuticals announces 20-to-1 reverse stock split

August 31, 2023 | markets.businessinsider.com

Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts

August 31, 2023 | finance.yahoo.com

Ampio Pharmaceuticals Announces Reverse Stock Split

August 3, 2023 | benzinga.com

Thinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?

June 22, 2023 | msn.com

3 Biotech Stocks to Buy With Explosive Upside Potential

See More Headlines

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/27/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NYSE:AMPE
CUSIP: N/A
CIK: 1411906
Web: ampiopharma.com
Phone: 720-437-6500
Fax: 720-437-6501
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($11.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,630,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -149.00%
Return on Assets: -103.79%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.41
Quick Ratio: 2.41

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.04 per share
Price / Book: 0.06

Miscellaneous

Outstanding Shares: 1,140,000
Free Float: 1,098,000
Market Cap: $285,000.00
Optionable: No Data
Beta: 1.95

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Michael A. Martino (Age 67)
CEO & Director
Comp: $550k
Mr. Daniel G. Stokely CPA (Age 60)
CFO, Corporate Secretary & Treasurer
Comp: $338.31k
Dr. David Bar-Or M.D. (Age 75)
Founder & Chairman of Scientific Advisory Board
Comp: $145.6k
April Ramirez
Clinical Trial Manager

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed in 2024?: Ampio Pharmaceuticals' stock was trading at $2.05 at the beginning of 2024. Since then, AMPE stock has decreased by 87.8% and is now trading at $0.25.
View the best growth stocks for 2024 here.
When is Ampio Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our AMPE earnings forecast.
How were Ampio Pharmaceuticals' earnings last quarter?: Ampio Pharmaceuticals, Inc. (NYSE:AMPE) released its quarterly earnings data on Wednesday, March, 27th. The company reported ($2.48) earnings per share for the quarter.
When did Ampio Pharmaceuticals' stock split?: Ampio Pharmaceuticals shares reverse split on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).
How do I buy shares of Ampio Pharmaceuticals?: Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AMPE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial